Cardiovascular Drugs Practice Questions

Q: Which drug is contraindicated in bilateral renal artery stenosis?

Captopril. **Explanation:** The correct answer is **Captopril (Option C)**. **Why Captopril is the correct answer:** In patients with **bilateral renal artery stenosis (RAS)**, the perfusion pressure to the kidneys is significantly reduced. To maintain an adequate Glomerular Filtration Rate (GFR), the body relies on the **Renin-Angiotensin-Aldosterone System (RAAS)**. Specifically, Angiotensin II causes **vasoconstriction of the efferent arteriole**, which creates the necessary back-pressure to maintain filtration. Captopril, an ACE inhibitor, prevents the formation of Angiotensin II. This leads to efferent arteriolar vasodilation, a sudden drop in intraglomerular pressure, and subsequent **acute renal failure**. Therefore, ACE inhibitors (and ARBs) are strictly contraindicated in bilateral RAS or RAS in a solitary functioning kidney. **Analysis of Incorrect Options:** * **A. Propranolol:** A non-selective beta-blocker. While it reduces renin release, it does not cause the acute hemodynamic collapse of GFR seen with ACE inhibitors. * **B. Guanethidine:** An older adrenergic neuron blocker. It lowers blood pressure by inhibiting norepinephrine release but does not specifically target the renal autoregulatory mechanism. * **D. Amlodipine:** A Calcium Channel Blocker (CCB). CCBs primarily dilate the *afferent* arteriole and are generally considered safe (and often preferred) in patients with renal artery stenosis. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Clue:** Suspect bilateral RAS if a patient’s serum creatinine rises by **>30%** after starting an ACE inhibitor or ARB. * **Drug of Choice:** CCBs or Beta-blockers are safer alternatives for hypertension in bilateral RAS. * **Teratogenicity:** ACE inhibitors are also contraindicated in pregnancy (Category X) due to fetal renal dysgenesis and skull hypoplasia.

Q: Which of the following is NOT true about fibrates?

Absorption is delayed by a fatty meal. **Explanation:** Fibrates (e.g., Gemfibrozil, Fenofibrate) are a class of lipid-lowering agents primarily used to target high triglyceride levels. **1. Why Option C is the correct (False) statement:** Contrary to the statement, the absorption of most fibrates is actually **enhanced**, not delayed, by a fatty meal. Fenofibrate, in particular, shows significantly improved bioavailability when taken with food. This is a high-yield pharmacological detail often tested to differentiate it from other drugs where food might impair absorption. **2. Analysis of other options:** * **Option A (True):** Fibrates are the **Drug of Choice (DOC)** for **Type III Hyperlipoproteinemia** (Dysbetalipoproteinemia) and **Severe Hypertriglyceridemia** (TG >500 mg/dL) to prevent acute pancreatitis. * **Option B (True):** Their primary mechanism involves activating **PPAR-alpha** (Peroxisome Proliferator-Activated Receptor-alpha). This leads to increased expression of **Lipoprotein Lipase (LPL)**, which enhances the catabolism of VLDL and triglycerides. * **Option D (True):** Common side effects include GI upset, skin rashes, urticaria, and myalgia. **Impotence** is a documented, though less common, side effect of clofibrate and other members of this class. **Clinical Pearls for NEET-PG:** * **Risk of Myopathy:** The risk of rhabdomyolysis increases significantly when fibrates (especially Gemfibrozil) are combined with **Statins**, as gemfibrozil inhibits the glucuronidation of statins, increasing their plasma levels. * **Gallstones:** Fibrates increase biliary cholesterol excretion, leading to a higher risk of **cholelithiasis** (gallstones). * **Contraindications:** Avoid in patients with severe hepatic or renal dysfunction and gallbladder disease.

Q: Which statin is not metabolized by CYP3A4?

Pravastatin. ### Explanation Statins (HMG-CoA reductase inhibitors) are primarily metabolized by the hepatic cytochrome P450 (CYP) enzyme system. Understanding these metabolic pathways is crucial for predicting drug-drug interactions. **1. Why Pravastatin is the Correct Answer:** Pravastatin is a **hydrophilic** statin. Unlike most other statins, it is not metabolized by the CYP450 system to any significant extent. Instead, it undergoes enzymatic degradation in the cytosol and is excreted unchanged. This makes it a preferred choice in patients taking multiple medications (polypharmacy) or drugs that are potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, protease inhibitors), as it carries a lower risk of drug-induced myopathy. **2. Analysis of Incorrect Options:** * **A, B, and C (Lovastatin, Simvastatin, Atorvastatin):** These are **lipophilic** statins. They are primarily metabolized by the **CYP3A4** isoenzyme. Co-administration of these drugs with CYP3A4 inhibitors leads to increased plasma concentrations of the statin, significantly increasing the risk of skeletal muscle toxicity (rhabdomyolysis). **3. NEET-PG High-Yield Clinical Pearls:** * **CYP3A4 Metabolized:** Simvastatin, Lovastatin, Atorvastatin (Mnemonic: **SLA**p the 3A4). * **CYP2C9 Metabolized:** Rosuvastatin and Fluvastatin. * **Non-CYP Metabolized:** Pravastatin and Pitavastatin (Safest regarding CYP interactions). * **Potency:** Rosuvastatin is the most potent statin, followed by Atorvastatin. * **Prodrugs:** Lovastatin and Simvastatin are administered as inactive lactones (prodrugs); others are active. * **Timing:** Statins with short half-lives (Simvastatin, Pravastatin) should be taken at **bedtime** because cholesterol synthesis peaks between midnight and 2:00 AM. Atorvastatin and Rosuvastatin have long half-lives and can be taken any time.

Q: Which of the following drugs is used in severe hypertensive emergencies, is very short acting, and must be given by i.v. infusion?

Nitroprusside. **Explanation:** **Sodium Nitroprusside** is the drug of choice for hypertensive emergencies because it is a potent, balanced vasodilator (acting on both arterioles and venules). Its mechanism involves the release of nitric oxide (NO), which increases cGMP levels, leading to smooth muscle relaxation. The key features that make it the correct answer are: 1. **Rapid Onset:** It acts within seconds. 2. **Ultra-short Duration:** Its effect lasts only 1–5 minutes after stopping the infusion, allowing for precise "minute-to-minute" titration of blood pressure. 3. **Administration:** It is unstable in light and must be administered via continuous intravenous infusion using an infusion pump. **Analysis of Incorrect Options:** * **Diazoxide (A):** An arteriolar vasodilator formerly used for emergencies. However, it has a long half-life (24 hours) and can cause reflex tachycardia and hyperglycemia, making it less ideal than Nitroprusside. * **Hydralazine (B):** Primarily an arteriolar vasodilator. It is used in pregnancy-induced hypertension (Eclampsia) but has a slower onset and less predictable offset compared to Nitroprusside. * **Labetalol (C):** A combined alpha and beta-blocker. While used in hypertensive emergencies (especially aortic dissection), it can be given as an IV bolus and has a much longer duration of action (3–6 hours). **High-Yield Clinical Pearls for NEET-PG:** * **Cyanide Toxicity:** Nitroprusside metabolism releases cyanide. Toxicity is managed with **Sodium Thiosulfate** (donates sulfur) or **Hydroxocobalamin** (binds cyanide to form Cyanocobalamin). * **Light Sensitivity:** Nitroprusside solutions must be wrapped in aluminum foil to prevent photodegradation. * **Thiocyanate Toxicity:** Prolonged infusion can lead to thiocyanate accumulation, especially in patients with renal failure, causing psychosis and seizures.

Q: Which of the following drugs acts as both a potassium channel opener and a nitric oxide donor?

Nicorandil. **Explanation:** **Nicorandil** is a unique anti-anginal agent characterized by a **dual mechanism of action**. It contains a nitrate moiety, allowing it to act as a **Nitric Oxide (NO) donor**, which increases cGMP levels leading to systemic venous dilation (preload reduction). Simultaneously, it acts as an **ATP-sensitive Potassium channel (K⁺$_{ATP}$) opener**, causing efflux of potassium, membrane hyperpolarization, and subsequent closure of voltage-gated calcium channels. This results in arterial dilation (afterload reduction). This balanced dilation of both epicardial coronary arteries and peripheral vessels makes it effective in stable angina. **Analysis of Incorrect Options:** * **B. Diazoxide:** This is a potent K⁺$_{ATP}$ channel opener used in hypertensive emergencies and insulinomas (as it inhibits insulin release). However, it lacks NO-donating properties. * **C. Sodium Nitroprusside:** A powerful vasodilator used in hypertensive crises. It acts solely as an NO donor (increasing cGMP) to dilate both arterioles and venules but does not affect potassium channels. * **D. Minoxidil:** A prodrug (converted to minoxidil sulfate) that acts strictly as a K⁺$_{ATP}$ channel opener. It is used for refractory hypertension and topically for alopecia. **High-Yield Clinical Pearls for NEET-PG:** * **Preconditioning:** Nicorandil mimics "ischemic preconditioning," protecting the myocardium during episodes of ischemia. * **Side Effects:** A highly specific and examiner-favorite side effect of Nicorandil is **perianal, oral, or mucosal ulceration**. * **Contraindication:** Like other nitrates, it should not be co-administered with PDE-5 inhibitors (e.g., Sildenafil) due to the risk of severe hypotension.

Q: Which of the following drugs can be used for the treatment of hypertension in a diabetic patient, EXCEPT?

Hydrochlorothiazide. **Explanation:** In diabetic patients with hypertension, the primary goal of therapy is not only blood pressure control but also **renoprotection** and **metabolic neutrality**. **Why Hydrochlorothiazide (HCTZ) is the correct answer:** Thiazide diuretics like Hydrochlorothiazide are generally avoided as first-line agents in diabetics because they can cause **hyperglycemia** and **dyslipidemia**. They inhibit insulin release from the pancreas and decrease peripheral glucose utilization, leading to worsened glycemic control. Additionally, they can cause hyperuricemia and hypokalemia. While they can be used in low doses as add-on therapy, they are the "least preferred" among the given options for a diabetic patient. **Analysis of other options:** * **Captopril (ACE Inhibitor) & Losartan (ARB):** These are the **drugs of choice** for hypertensive diabetics. They provide significant renoprotection by dilating the efferent arteriole, reducing intraglomerular pressure, and slowing the progression of diabetic nephropathy (reducing albuminuria). * **Amlodipine (Calcium Channel Blocker):** CCBs are metabolically neutral, meaning they do not affect blood glucose or lipid levels. They are excellent second-line agents or alternatives if ACE inhibitors are not tolerated. **NEET-PG High-Yield Pearls:** * **DOC for HTN with Diabetes:** ACE Inhibitors (e.g., Enalapril) or ARBs (e.g., Telmisartan). * **Metabolic effects of Thiazides:** Remember the mnemonic **"Hyper-GLUC"** (Hyper-Glycemia, Hyper-Lipidemia, Hyper-Uricemia, Hyper-Calcemia). * **Beta-blockers in Diabetes:** Use with caution as they can mask the tachycardia associated with hypoglycemia (except for non-selective ones like Propranolol, which can also delay recovery from hypoglycemia). Carvedilol/Nebivolol are preferred if a BB is necessary.

Question 1

Which drug is contraindicated in bilateral renal artery stenosis?

Accepted Answer

Captopril

Answer

Propranolol

Answer

Guanethidine

Answer

Amlodipine

Question 2

Sudden withdrawal of which of the following drugs could result in serious adverse cardiovascular changes in a patient taking the drug over a long time?

Accepted Answer

Clonidine (α2 agonist)

Answer

Phenelzine (MAO inhibitor)

Answer

Enalapril (ACE inhibitor)

Answer

Fluoxetine (serotonin reuptake inhibitor)

Question 3

What is the biochemical mechanism of action of digitalis?

Accepted Answer

An increase in systolic intracellular calcium levels

Answer

An increase in conduction from the atria to the ventricle

Answer

An increase in ATP synthesis

Answer

A block of calcium channels

Question 4

Which of the following is NOT true about fibrates?

Accepted Answer

Absorption is delayed by a fatty meal

Answer

Drug of choice for type III hyperlipoproteinemia and severe hypertriglyceridemia

Answer

Activate PPAR-alpha to stimulate LPL

Answer

Side effects include rash, urticaria, myalgia, and impotence

Question 5

Enalapril increases the levels of which of the following?

Accepted Answer

Bradykynin

Answer

Interferon

Answer

Platelet-activating factor (PAF)

Answer

Tumor necrosis factor (TNF)

Question 6

All of the following drugs can be used in hypertensive crisis except?

Accepted Answer

Pindolol

Answer

Labetalol

Answer

Nitroprusside

Answer

Nifedipine

Question 7

Which statin is not metabolized by CYP3A4?

Accepted Answer

Pravastatin

Answer

Lovastatin

Answer

Simvastatin

Answer

Atorvastatin

Question 8

Which of the following drugs is used in severe hypertensive emergencies, is very short acting, and must be given by i.v. infusion?

Accepted Answer

Nitroprusside

Answer

Diazoxide

Answer

Hydralazine

Answer

Labetalol

Question 9

Which of the following drugs acts as both a potassium channel opener and a nitric oxide donor?

Accepted Answer

Nicorandil

Answer

Diazoxide

Answer

Sodium nitroprusside

Answer

Minoxidil

Question 10

Which of the following drugs can be used for the treatment of hypertension in a diabetic patient, EXCEPT?

Accepted Answer

Hydrochlorothiazide

Answer

Losartan

Answer

Captopril

Answer

Amlodipine

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?